Navigation Links
Geneticist Svante Pääbo receives the $500,000 Gruber Genetics Prize
Date:2/19/2013

Svante Pbo, PhD, director of the Department of Genetics at the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, is the recipient of the 2013 Genetics Prize of The Gruber Foundation. Pbo is being honored with this prestigious international award for his pioneering research in the field of evolutionary genetics. He is considered the founder of molecular paleontology, the application of genetics to the study of prehistoric life.

The award will be presented to Pbo on April 16 at the International Congress of Genetics conference in Singapore, where he will also deliver a lecture entitled "Archaic Genomics."

"Svante Pbo's work shows basic science at its best. He was driven by an obvious passion to use DNA technology to unlock the past. He overcame seemingly insupperable technical obstacles. And he opened new vistas on a question we all care about, 'Where do we come from?' This is a wonderful award," said Maynard Olson, a member of the selection advisory board and 2007 laureate of the Gruber Genetics Prize.

Pbo, 57, started experimenting with extracting DNA from ancient human remains in the early 1980s while completing his PhD program in molecular immunology at the University of Uppsala in Sweden, his native country. His first major findingthe demonstration that DNA was preserved in a 2,400-year-old mummy of an infant boywas published as the cover story in Nature in 1985. In the ensuing two-and-a-half decadesat the University of California at Berkeley, the University of Munich and, since 1997, at the Max Planck Institute Pbo has played a leading role in developing the technology that has made it possible to isolate and sequence ancient DNA.

In 1997, Pbo announced the successful sequencing of mitochondrial Neandertal DNAa watershed in evolutionary genetics. In addition to proving that the DNA could be successfully extracted and sequenced from a 40,000-year-old fossil, the sequencing showed that Neandertals
'/>"/>

Contact: A. Sarah Hreha
info@gruber.yale.edu
203-432-6231
Yale University
Source:Eurekalert

Page: 1 2

Related biology news :

1. National Academy of Sciences honors geneticist and biologist Sue Biggins
2. Geneticist develops tool to identify genes important in disease, tailoring individual treatment
3. Renowned geneticist R. Rodney Howell receives ACMG Foundation Lifetime Achievement Award
4. Artificial retina receives FDA approval
5. NTU Provost receives prestigious Imperial College fellowship joining the ranks of top UK scientists
6. Xenon Receives a Milestone Payment for Marketing Approval of Glybera in Europe
7. Brainwave "Balancing" Research Receives $1 Million Grant From The Susanne Marcus Collins Foundation, Inc.
8. Celladon Corporation Receives Notice of Allowance from United States Patent and Trademark Office
9. Univ. of Miami profs Chen and Soden named Fellows of AMS, Albrecht receives AMS Teaching Award
10. Childrens Hospital of Philadelphia receives federal grant to improve health care decision-making
11. Bloomberg School receives $28 million for family planning advocacy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased ... State of Washington,s Department of Licensing, ... and central issuance system for driver,s licenses and identification cards ... planning and development will start in January 2015, with enrollment ...
(Date:1/22/2015)... , Jan. 16, 2015  A man-made form of ... and other mental capabilities in adults with mild cognitive ... study led by researchers at Wake Forest Baptist Medical ... diagnosed with amnesic mild cognitive impairment (MCI) or mild ...
(Date:1/22/2015)... and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ) has ... Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, ... report to their offering. , ... be worn on the user,s body and have ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2
... Ore. In ecosystems around the world, the decline of ... is changing the face of landscapes from the tropics to ... published today in the journal Science shows for ... by humans and loss of prey combine to create global ...
... A team of scientists at LSU Health Sciences Center ... of E6-associated protein (E6AP), an enzyme that acts as a ... time, that the active form of E6AP is composed of ... the ability of nerve cells to "rewire" themselves in response ...
... new technology to squeeze more energy from the fuel release ... power plants do, according to a new analysis accepted for ... of the American Geophysical Union. The so-called "combined cycle" natural ... sulfur dioxide, which can worsen air quality. "Since more ...
Cached Biology News:Loss of large carnivores poses global conservation problem 2Loss of large carnivores poses global conservation problem 3LSUHSC research reveals structure of master regulator and new drug target for autism, cervical cancer 2New study: US power plant emissions down 2
(Date:1/22/2015)... SAN DIEGO , Jan. 22, 2015   ... company, and Sequenom, Inc. (NASDAQ: SQNM ... a development agreement for next generation noninvasive prenatal ... Cypher,s genome interpretation technology, called Mantis™, to advance ...
(Date:12/24/2014)... Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval application ... the use of Medtronic,s SynchroMed ® II implantable ... use with United Therapeutics, Remodulin ® (treprostinil) Injection ...
(Date:12/24/2014)... Louis, Missouri (PRWEB) December 23, 2014 GMO ... biotechnology company, Syngenta, are in the process of being consolidated ... case is In Re: Syngenta AG MIR 162 Corn Litigation, ... District of Kansas. , Management of the Syngenta GMO corn ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 The ... as its definition, classification, application and industry overview. ... and product cost structure. Production is separated by ... upstream raw materials, equipment, downstream client survey, marketing ...
Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2
... 7 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc.,(TSX:SDI) today ... the fiscal year ended December 31, 2007., ... its EAA(TM) Endotoxin,Activity Assay, the only FDA ... is a systemic response to bacterial toxins ...
... CLARA, Calif., March 7 Finesse Solutions, LLC, ... sciences process,applications, and Nova Biomedical, Waltham, MA, a ... TruBio(TM) OS plug-in,for OPC connectivity between TruBio(TM) OS ... Basic 2 analyzers. Both companies confirmed that a,TruBio(TM) ...
... SAN DIEGO, March 6 Cadence Pharmaceuticals,Inc. (Nasdaq: ... in-licensing,developing and commercializing proprietary product candidates principally,for use ... will release its,fourth quarter and full year ended ... market on Wednesday, March 12, 2008., Cadence ...
Cached Biology Technology:Spectral announces 2007 financial results 2Spectral announces 2007 financial results 3Spectral announces 2007 financial results 4Spectral announces 2007 financial results 5Spectral announces 2007 financial results 6Spectral announces 2007 financial results 7Spectral announces 2007 financial results 8Spectral announces 2007 financial results 9Finesse Solutions, LLC Announces OPC Connectivity With Nova BioProfile 400 2Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results and Clinical Program Overview on March 12, 2008 2
See product name for description....
Request Info...
G-Protein Coupled Receptor Assay, For 500 assays. SPA. Category: Drug Screening & Cellular Assays, Assays ....
Panomer 9 oligodeoxynucleotides are random primers that are labeled at the 5' end with our proprietary QSY 7 dye and they are useful for assessing microarray spot morphology, hybridization potential ...
Biology Products: